相关实验视频
Updated: Feb 13, 2026

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.8K
贝扎菲布拉特在CBA/N小鼠中延长了由A1腺素受体激动剂诱导的低温
Miho Sato-Hashimoto1, Hiroshi Ohnishi2,3
1Department of Animal Pharmaceutical Science, School of Pharmaceutical Sciences, Kyushu University of Medical Science.
The Journal of veterinary medical science
|February 11, 2026
概括
贝扎纤维酸 (BZ) 增强了小鼠中腺素受体激动剂的低温作用. 这种预处理可以延长低体温并减少能量消耗,这表明PPARα和A1AR通路之间的协同关系.
科学领域:
- 生理学 生理学 生理学
- 药理学 药理学是指药理学的学科.
- 代谢研究的研究.
背景情况:
- 温度调节和低温在家庭热剂中至关重要.
- 氨酸A1受体 (A1AR) 参与控制体温.
研究的目的:
- 研究贝扎纤维酸 (BZ) 和A1AR激动剂对温度调节的联合作用.
- 探索PPARα和A1AR在调节低温症中的潜在协同关系.
主要方法:
- 小鼠接受了BZ补充食品的预治疗,这是一种过氧酶增殖器激活受体α (PPARα) 激动剂.
- 通过使用A1ARagonist N6-cyclohexyladenosine (CHA) 诱导低温.
- 监测了体温,氧气消耗,二氧化碳排放和能源消耗.
主要成果:
- BZ预治疗显著延长了CHA诱导的低温 (低体温<33°C) 的持续时间,从1小时以下延长到6小时.
- 与单独使用CHA相比,联合处理导致氧气消耗,二氧化碳产量和能源支出减少.
- 由BZ诱导的PPARα激活增强了A1AR敏感性,延长了低温.
结论:
- PPARα的激活会增强A1AR介导的低温效应.
- 建议PPARα和A1AR在控制和冬眠方面的协同关系.
- 通过PPARα信号的代谢激活脂质代谢可能会增强A1AR诱导的低温症.
相关概念视频
Glucagon-like Receptor Agonists
1.0K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
Drug-Receptor Interaction: Agonist
4.2K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.2K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.0K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
524
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
524
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K

